Modular Medical Secures Major Contract with National PBM

Modular Medical, Inc., a commercial-stage medical device company, has secured a significant contract with a national U.S. pharmacy benefit manager (PBM), expanding access to its next-generation Pivot™ tubeless patch pump. The agreement, announced on September 4, 2026, marks a substantial step forward in making the innovative insulin delivery system available to a broader patient base.

According to Jeb Besser, Chief Executive Officer of Modular Medical, the partnership with a national PBM, one of the largest in the country, is a pivotal commercialization milestone for the Pivot patch pump. "PBMs play a critical role in enabling patient access to therapies and medical technologies," Besser noted. "This relationship positions us to reach more patients who could benefit from a simpler, more approachable insulin-delivery solution."

Pharmacy benefit managers, such as the one Modular Medical has partnered with, serve a central role in the U.S. healthcare ecosystem by facilitating the availability of prescription drugs through health plans, employers, and pharmacies. By working with PBMs, Modular Medical aims to streamline access to its Pivot tubeless patch pump, which offers a continuous subcutaneous insulin infusion with both basal and bolus delivery over a three-day wear period. This system is designed to provide a practical and accessible pathway for people living with diabetes, moving from multiple daily injections to insulin pump therapy.

Modular Medical, Inc. is dedicated to developing innovative insulin delivery technologies to simplify diabetes management and increase access to insulin pump therapy. The company's Pivot™ tubeless patch pump is part of its ongoing efforts to meet the needs of individuals requiring intensive insulin therapy.

The agreement with the national PBM is expected to expand patient access to the Pivot patch pump, validating it as a viable and accessible therapeutic option for people with diabetes. However, the company acknowledges the risks and uncertainties associated with the contract, including the potential for market acceptance and successful manufacturing at high volumes.

Besser stated, "We believe this agreement with a national PBM will help us reach more patients who could benefit from our innovative technology. As healthcare stakeholders continue to focus on improving outcomes while managing costs, solutions that offer ease of use and effective diabetes management are increasingly important."

Modular Medical faces ongoing challenges, including the need for market acceptance of its products and services, anticipated consumer demand, and successful manufacturing at high volumes. The company notes that these factors, along with general economic and industry conditions, could impact its future success.

In summary, the contract with the national PBM is a significant step forward for Modular Medical, marking a critical milestone in the commercialization of its Pivot tubeless patch pump. The partnership aims to enhance patient access to a simpler and more approachable insulin-delivery solution, ultimately improving the lives of those living with diabetes.